( March 13, 2026, 8:59 AM EDT) -- WASHINGTON, D.C. — In an amicus curiae brief filed in support of neither party, the Intellectual Property Owners Association (IPO) told the U.S. Supreme Court that the standard for inducement of infringement should be applied universally in patent cases, including in “skinny label” cases involving an allegedly noninfringing use; IPO tells the high court that the petitioner bioequivalent pharmaceutical maker appears to be advocating for multiple “bright-line” rules that should not be applied....